From Tea Catechins to Microbial Metabolites: Emerging Mechanisms for Modulating Gut-Origin α-Synuclein Seeding in Parkinson’s Disease
Nutrients · 2026
DOI: 10.3390/nu18203304 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Ali Rehman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health Sciences, University of Georgia, Athens, GA 30605, USA. Hauptthemen laut MEDLINE: Catechin, alpha-Synuclein, Parkinson Disease, Gastrointestinal Microbiome. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Agriculture, USDA NIFA.
Abstract (Originalsprache)
Parkinson’s disease (PD) is increasingly recognized as a heterogeneous neurodegenerative disorder with multiple clinical and pathological trajectories. In a subset of patients, α-synuclein pathology may begin in the gut and subsequently spread to the brain, a pathway most relevant to the proposed body-first subtype of PD. Tea catechins, particularly epigallocatechin-3-gallate (EGCG), can influence α-synuclein aggregation, oxidative stress, inflammatory signaling, and gut microbial ecology. Because their systemic bioavailability is limited, substantial amounts reach the intestine and undergo microbiota-dependent biotransformation. This review examines whether parent catechins and their microbial metabolites could modify intestinal processes relevant to α-synuclein misfolding and seeding. Evidence indicates that catechins are converted into phenyl-γ-valerolactones and lower-molecular-weight phenolic metabolites, while microbial amyloids such as curli can promote α-synuclein aggregation in experimental models. EGCG can also remodel α-synuclein assemblies, and catechin exposure can alter microbial and inflammatory phenotypes. However, direct evidence that catechin-derived microbial metabolites inhibit curli–α-synuclein cross-seeding or reduce enteric α-synuclein seeding remains limited. By distinguishing general neuroprotection from effects on aggregation, seeding, and disease modification, this review integrates current evidence and highlights the potential relevance of microbiota-dependent catechin metabolism to gut-origin α-synuclein pathology and body-first PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental Health Sciences, University of Georgia, Athens, GA 30605, USA.
ORCID-Profile: Ali Rehman, Lili Tang
Förderung
- United States Department of Agriculture
- USDA NIFA
Zitieren
APA
Rehman, A., & Tang, L. (2026). From Tea Catechins to Microbial Metabolites: Emerging Mechanisms for Modulating Gut-Origin α-Synuclein Seeding in Parkinson’s Disease. Nutrients. https://doi.org/10.3390/nu18203304
Vancouver
Rehman A, Tang L. From Tea Catechins to Microbial Metabolites: Emerging Mechanisms for Modulating Gut-Origin α-Synuclein Seeding in Parkinson’s Disease. Nutrients. 2026. doi:10.3390/nu18203304
BibTeX
@article{Rehman2026,
author = {Rehman, Ali and Tang, Lili},
title = {From Tea Catechins to Microbial Metabolites: Emerging Mechanisms for Modulating Gut-Origin α-Synuclein Seeding in Parkinson’s Disease},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18203304}
}
EUVIMED